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Abstract
The advance of high-throughput next-generation sequencing technology makes possible the analysis of rare
variants. However, the investigation of rare variants in unrelated-individuals data sets faces the challenge of low
power, and most methods circumvent the difficulty by using various collapsing procedures based on genes,
pathways, or gene clusters. We suggest a new way to identify causal rare variants using the F-statistic and sliced
inverse regression. The procedure is tested on the data set provided by the Genetic Analysis Workshop 17
(GAW17). After preliminary data reduction, we ranked markers according to their F-statistic values. Top-ranked
markers were then subjected to sliced inverse regression, and those with higher absolute coefficients in the most
significant sliced inverse regression direction were selected. The procedure yields good false discovery rates for the
GAW17 data and thus is a promising method for future study on rare variants.
Background
There is a growing interest in the role of rare variants in
disease etiology—rare in the sense that the minor allele
frequency (MAF) is less than 1%. Earlier genome-wide
association studies identified risk loci that accounted for
only 5–10% of disease heritability [1]. There is now an
increasing body of evidence that suggests an association
between the rare variants and complex diseases [2].
However, the small variance of rare variants makes their
association with phenotypes difficult to detect. To
increase the detection power of such associations, most
existing methods collapse the rare variants using biolo-
gical information. Some of these collapsing methods are
based on genes or pathways, whereas others involve
functionality, synonymous single-nucleotide polymorph-
isms (SNPs), or nonsynonymous SNPs [3]. Although the
collapsing methods increase the allele frequency so that
the risk effect is amplified, the noise in the collapsed
variables may also increase. This could render the col-
lapsing method less effective in some cases.
In this paper, we propose a three-step method that
does not use collapsing. After removing the SNPs that
are identical in value across all subjects in the data, we
calculate the F-statistic for all the markers. We show
that the F-statistic does not down-weight a rare variant
despite its low allele frequency and thus is effective in
capturing the effect of the rare variant. Next, we apply
sliced inverse regression (SIR) to top-ranked markers
selected by the F-statistic. When the number of selected
top markers is not too large, we find that SIR performs
well in identifying the SNPs used to simulate the
Genetic Analysis Workshop 17 (GAW17) phenotypes
from the top markers (hereafter these SNPs are referred
to as the answers).
Methods
Data set
The data set [4] from GAW17 consists of 24,487 SNPs
and 697 unrelated individuals. The genotypes are real
sequencing data from the 1000 Genomes Project. In
particular, rare variants (i.e., MAF < 1%) make up 74%
of the total variants. Based on the same genotypes, 200
replications are simulated. Four phenotypes are available
for analysis: the quantitative traits Q1, Q2, Q4, and the
disease affected status. In this paper, we use Q1 to
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9 genes. Although the method is applicable to Q2,
which is influenced by 72 SNPs in 13 genes, the result
is not reported here. Q4 is too noisy to obtain meaning-
ful conclusions. Our method does not require any infor-
mation on the answers, although we use the information
to assess the performance of the method.
Preliminary data reduction
Because most of the SNPs are rare variants, many of
them take identical values across all individuals in the
data set; that is, statistically they are indistinguishable.
In the preliminary data reduction step, we remove the
identical-valued SNPs and keep track of them for later
reference. By doing so, we reduce the 24,487 SNPs to
15,124 distinguishable markers. The benefit of this pro-
cedure is twofold. First, the dimension is reduced for
subsequent statistical analysis, and, second, removing
identical-valued SNPs prevents the numerical problems
caused by degenerate matrices in regression and princi-
pal component types of analyses.
Selection by F-statistics
The F-statistic, as defined in the simple linear regression
model, takes the form:
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where:
Yi=b0+ b1X1i+εI
is the simple regression model for ith observation
i=1 , …,n using standard notations. In particular, εi are
independent normally distributed random variables
with mean 0 and variance s
2.L e tY be the sample
mean of Y’s. SSR and SSE are the regression sum of
squares and the error sum of squares, respectively. The
estimated model is:
YX i i   =+ bb 01 1 (2)
We calculate the F-statistic for each of the 15,124
markers by fitting a simple linear regression model, one
marker at a time. The response variable Y is the average
value of Q1 over 10 replications. The markers are then
ranked by F values. A number of top markers are
selected for further analysis in the next step.
Selection by sliced inverse regression
SIR [5] is a nonparametric regression method that uses
local smoothing of the response variable. It retrieves
high-dimension data features from low-dimensional
projection. After standardizing X,w ee s t i m a t ea n
inverse regression of X on sliced Y. The inverse regres-
sion, that is, the computation of E(X|Y), converts a
high-dimensional regression problem of Y on X to
many simple regressions of X on Y.I ne s t i m a t i n gE(X|
Y), the range of Y is divided into small intervals
(sliced) to increase computational efficiency. Next, we
perform a principal components analysis on E(X|Y),
and the principal components (PCs) are returned.
These are the SIR effective dimension reduction direc-
t i o n sd i s c u s s e db yL i[ 5 ] .W es i m p l yc a l lt h e mt h eS I R
directions. In our analysis, SIR is performed using the
R package dr.
Top markers selected from the previous step are
subjected to SIR, and the response variable of SIR is the
same as the one used in the previous step of determin-
ing the F-statistic. Because the first SIR direction (DIR1)
contains the most important information of the data, it
is the most significant, and we use only this SIR
direction in our method. Next, we perform a two-mean
clustering analysis on the absolute DIR1 coefficients.
The markers in the cluster with higher mean are our
final candidates for causal SNPs.
Results
Our method is first applied to data from replicates 1 to
10 (group 1). To assess the false discovery rate (FDR) of
our method, we divided the 200 replications of the
GAW17 data set into 20 groups with 10 replicates per
group (i.e., replicates 11 to 20 are group 2, replicates 21
to 30 are group 3, etc.). We average the ratios of the
number of identified answers to the number of final
candidate SNPs over 20 groups to obtain the FDR.
Performance of the F-statistic
For the group 1 data, there are eight answers in the top
100 markers ranked by the F-statistic (Table 1), and
seven of them are in the top 32. The identified answers
come from four different genes, and their MAFs range
from 0.1% to 6.7%. We also identified rare variants with
only one minor allele (C4S1877 and C4S1889), and the
b (influence level) of the answers were all relatively
high. This result shows that the answers found by the F-
statistic have strong main risk effects.
How many top markers should be used?
We need to select a number of top markers for
further analysis. First, the p-value of DIR1 reported
by the SIR provides us with a clue regarding an upper
bound for the number of markers to be selected. In
the group 1 data, with 70 markers or less, the p-value
of DIR1 are all well below 0.1%, but with 80 markers
the p- v a l u er i s e sb ym o r et h a n2 0t i m e s ,t o2 % .T h i s
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used should be at most 70. Second, the histograms of
the F-statistic show a clear gap at about the top 30th
position for most of the 20 groups. Thus we use the
top 30th marker as the cutoff position. The results of
the other cutoff positions are also calculated (Table
2). We observe that there is a trade-off between the
FDR and the number of answers found. The number
of answers increases with the number of markers
used; however, the FDR also increases. Selecting the
top 30 markers gives the best balance between the
two. The performance of the proposed method for
each of the 20 groups is shown in Table 3. In this
case, the FDR is 20.8% and the average number of
answers found is 4.3.
Performance of SIR
With the top 30 markers from the last step, for group
1, we selected five markers through SIR, and all of
them are answers. Figure 1 plots the absolute coeffi-
cients of DIR1. We observe that all five answers
(marked by dashed lines) reside on peak positions. A
similar phenomenon is also observed in the other
groups. Using more markers does bring in more false
positives, but the answers still occupy the peak posi-
tions. Figure 2 shows the SIR plot using the top 50
markers. In the GAW17 meeting, many research teams
reported a large number of consistent false positives
with high FDRs. Our analysis shows that SIR can help
to eliminate these false positives and that it has good
power to identify causal SNPs.
Discussion
Why does the F-statistic work for rare variants?
We explain why the F-statistic works for rare variants by
using a rare variant with only one minor allele (private
variant). When the explanatory variables (x1, …, xn)a r e
binary, the F-statistic in Eq. (1) is the same as the F-sta-
tistic for comparing multiple group means. We decom-
pose the numerator into two parts: In the first part x1 is
the minor allele, and in the second part xi,i=2, …, n,a r e
all major alleles. The decomposition in the following
equation shows the weights given to the two parts and
provides an insight into the power of the F-statistic for
a rare variant:
SSR =−+ − − − () ( ) ( ) , xx n x x n 1
2
1
2 1 (3)
Table 1 Answers in the top 100 markers identified by the F-statistic in the group 1 data
Collapsed sequence Original sequence Gene Rank in selected markers SNP MAF b
10648 16705 FLT1 1 C13S523 0.066714 0.64997
10647 16704 FLT1 2 C13S522 0.027977 0.6183
10640 16692 FLT1 11 C13S431 0.017217 0.74136
571 5386 KDR 17 C4S1877 0.000717 1.07706
571 (identical) 5392 KDR 17 C4S1889 0.000717 0.94133
10649 16706 FLT1 28 C13S524 0.004304 0.62223
994 1153 ARNT 32 C1S6533 0.011478 0.5619
3627 5390 KDR 66 C4S1884 0.020803 0.29558
Table 2 Trade-off between FDR and the number of
identified answers
Number of input
markers to SIR
FDR (20
groups) (%)
Average number of identified
answers (20 groups)
10 12.7 2.75
30 20.8 4.3
50 37.7 4.8
70 38.5 3.9
80 47.7 5
Table 3 Performance of SIR in 20 groups with top 30
markers FDR = 20.8%
Group Number of
identified
answers (A)
Number of
candidate
markers (B)
Ratio of A to
B (%)
(B − A)/B
(%)
1 5 5 100.0 0.0
2 4 4 100.0 0.0
3 4 6 66.7 33.3
4 4 6 66.7 33.3
5 4 6 66.7 33.3
6 4 6 66.7 33.3
7 5 6 83.3 16.7
8 5 5 100.0 0.0
9 5 6 83.3 16.7
10 4 5 80.0 20.0
11 4 4 100.0 0.0
12 4 5 80.0 20.0
13 6 8 75.0 25.0
14 3 4 75.0 25.0
15 4 6 66.7 33.3
16 3 4 75.0 25.0
17 5 6 83.3 16.7
18 6 7 85.7 14.3
19 4 5 80.0 20.0
20 3 6 50.0 50.0
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The first part on the right-hand side of Eq. (3) can be
written:
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Thus the weight given to the regression sum of
squares (SSR) for the minor allele is (n − 1) times that
for the major allele. This helps to manifest the effects of
rare variants on the response.
Simultaneous versus separate treatment of common and
rare variants
In the preceding analysis, we calculated the F-statistic
for both common and rare variants simultaneously.
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Figure 1 Selection by sliced inverse regression (30 markers).
For group 1, using 30 top markers, the absolute values of the first SIR
direction coefficients are plotted in sequence. Dashed lines indicate
the answer SNPs. Two-mean clustering is performed on the absolute
coefficients. The red circles represent the markers in the cluster with a
higher mean, which are our final selections. The green circles represent
markers in the other cluster. Other groups produce similar plots. In this
case, five out of five selected markers are answers.
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Figure 2 Selection by sliced inverse regression (50 markers). Please refer to Figure 1 for explanation. Note that, although more false
positives are selected, all answers are still included among the final candidates for causal SNPs.
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further interesting findings. After removing identical
SNPs, we reduce the 9,433 private variants to 685 distin-
guishable markers. In the group 1 data, among the top
20 markers ranked by F-statistic, five answers are found.
Three of them are new (CAS4935, C4S1873, and
C4S1887) to the previously identified SNPs when apply-
ing the F-statistic to all markers. This suggests that a
separate treatment of common and rare variants is a
promising strategy for further investigation.
Conclusions
We use traditional statistical methods for new applica-
tions in the context of rare variant research. A three-
step method is introduced. First, we perform a simple
data reduction by removing identical-valued SNPs. Sec-
ond, we calculate F-statistics on all markers and select
those with the top F values. Finally, we perform SIR on
the top markers and perform two-mean clustering on
the absolute coefficients of the first SIR direction. Mar-
kers in the cluster with a higher mean are the final can-
didates for causal SNPs. Using the top 30 markers from
the F-statistic, we find that the FDR is 20.8% and that
the average number of answers is 4.3. We show that the
proposed method is an effective and easy-to-use feature
selection approach in the context of rare variants.
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